New Preliminary Real-World VEOZAH™ (fezolinetant) Data Highlights Improvements in Menopause-Related Symptoms and Sleep Outcomes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Astellas Pharma Inc Unsponsored ADR (AMEX: ALPMY) | Delayed: 15.84 +0.16 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.68 | 52 Week High | $19.40 | |||
| Open | $15.85 | 52 Week Low | $12.50 | |||
| Day High | $15.90 | P/E | N/A | |||
| Day Low | $15.75 | EPS | $0.00 | |||
| Volume | 38,743 | |||||
